Marcaine is one of 61 small molecule programs targeting Total Knee Arthroplasty. It is currently in Phase 1.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
66 competitors in Total Knee Arthroplasty
Cyklokapron
Marcaine
Decadron
Medrol
Carbocaine
Lexapro
Epidiolex
Duragesic
MS Contin
Celebrex
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details